

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.52741365 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52741365 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.24000142 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24000142 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.71671821 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.98639746 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.98639746 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.98639746 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.97239459 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.77596975 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.77476839 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.68470602 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.56916881 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.50539680 |
| 15 | cysteine metabolic process (GO:0006534) | 5.43789126 |
| 16 | lysine metabolic process (GO:0006553) | 5.27212498 |
| 17 | lysine catabolic process (GO:0006554) | 5.27212498 |
| 18 | urea cycle (GO:0000050) | 5.26495244 |
| 19 | urea metabolic process (GO:0019627) | 5.26495244 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.18691974 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17262825 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.06123857 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05231436 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.00646871 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96042360 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93461303 |
| 27 | protein carboxylation (GO:0018214) | 4.93461303 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.90769098 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.84931219 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.82461067 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.80332436 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.76508390 |
| 33 | bile acid metabolic process (GO:0008206) | 4.75528256 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.72625010 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.64716050 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.61965624 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.61961858 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.56488645 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.53980586 |
| 40 | NADH metabolic process (GO:0006734) | 4.47994236 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.45860440 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.42286374 |
| 43 | regulation of complement activation (GO:0030449) | 4.40412316 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.39197577 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.39197577 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34538472 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.34538472 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.34538472 |
| 49 | drug catabolic process (GO:0042737) | 4.33523021 |
| 50 | cellular amino acid catabolic process (GO:0009063) | 4.31375067 |
| 51 | fructose metabolic process (GO:0006000) | 4.30995298 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 4.30133470 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.27437930 |
| 54 | drug transmembrane transport (GO:0006855) | 4.26735824 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.25653613 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.25653613 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 4.25114556 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 4.24406051 |
| 59 | glutamate metabolic process (GO:0006536) | 4.23355594 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.20453983 |
| 61 | phospholipid efflux (GO:0033700) | 4.18574699 |
| 62 | urate metabolic process (GO:0046415) | 4.16007991 |
| 63 | glycine metabolic process (GO:0006544) | 4.12521179 |
| 64 | amine catabolic process (GO:0009310) | 4.08358890 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 4.08358890 |
| 66 | cellular glucuronidation (GO:0052695) | 4.04619601 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.02654178 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.02652344 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.99233261 |
| 70 | proline metabolic process (GO:0006560) | 3.98947203 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98606392 |
| 72 | ketone body metabolic process (GO:1902224) | 3.95728162 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 3.95274003 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.92345597 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 3.92287616 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 3.90969771 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.88190087 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.86363733 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.86199607 |
| 80 | proline biosynthetic process (GO:0006561) | 3.85864720 |
| 81 | L-serine metabolic process (GO:0006563) | 3.84275342 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.81769163 |
| 83 | organic acid catabolic process (GO:0016054) | 3.81769163 |
| 84 | acetyl-CoA metabolic process (GO:0006084) | 3.81394394 |
| 85 | cholesterol efflux (GO:0033344) | 3.79500639 |
| 86 | ethanol oxidation (GO:0006069) | 3.78170821 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77949902 |
| 88 | arginine metabolic process (GO:0006525) | 3.76895899 |
| 89 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.73770071 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.70963822 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.66950100 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.66950100 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.65996223 |
| 94 | fatty acid beta-oxidation (GO:0006635) | 3.63386870 |
| 95 | fatty acid oxidation (GO:0019395) | 3.60830789 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60361005 |
| 97 | cofactor catabolic process (GO:0051187) | 3.59617676 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59495246 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59495246 |
| 100 | flavonoid metabolic process (GO:0009812) | 3.58141366 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 3.57916538 |
| 102 | drug transport (GO:0015893) | 3.55753965 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.55341136 |
| 104 | lipid oxidation (GO:0034440) | 3.53720283 |
| 105 | fibrinolysis (GO:0042730) | 3.53347222 |
| 106 | drug metabolic process (GO:0017144) | 3.52494348 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49432170 |
| 108 | carnitine metabolic process (GO:0009437) | 3.49248859 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.49090943 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.39597991 |
| 111 | intestinal absorption (GO:0050892) | 3.36690424 |
| 112 | gluconeogenesis (GO:0006094) | 3.35310958 |
| 113 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.24051956 |
| 114 | hexose biosynthetic process (GO:0019319) | 3.23459300 |
| 115 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.20490703 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.20322188 |
| 117 | monosaccharide biosynthetic process (GO:0046364) | 3.12323766 |
| 118 | phenylpropanoid metabolic process (GO:0009698) | 3.05637031 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.00448252 |
| 120 | 4-hydroxyproline metabolic process (GO:0019471) | 2.99041571 |
| 121 | ethanol metabolic process (GO:0006067) | 2.95383610 |
| 122 | vitamin biosynthetic process (GO:0009110) | 2.91037495 |
| 123 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.90529969 |
| 124 | heme transport (GO:0015886) | 2.86848943 |
| 125 | angiotensin maturation (GO:0002003) | 2.86556228 |
| 126 | glucose 6-phosphate metabolic process (GO:0051156) | 2.85913274 |
| 127 | creatine metabolic process (GO:0006600) | 2.81105548 |
| 128 | ribosomal small subunit biogenesis (GO:0042274) | 2.76151450 |
| 129 | L-ascorbic acid metabolic process (GO:0019852) | 2.75992869 |
| 130 | DNA unwinding involved in DNA replication (GO:0006268) | 2.75835833 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 2.73545974 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 2.70015746 |
| 133 | regulation of cholesterol metabolic process (GO:0090181) | 2.66546748 |
| 134 | fatty acid catabolic process (GO:0009062) | 2.64898176 |
| 135 | glutamine family amino acid catabolic process (GO:0009065) | 2.63332452 |
| 136 | tetrahydrofolate metabolic process (GO:0046653) | 2.62430092 |
| 137 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61885617 |
| 138 | diacylglycerol metabolic process (GO:0046339) | 2.58557742 |
| 139 | protein-lipid complex subunit organization (GO:0071825) | 2.58049437 |
| 140 | glutamine family amino acid metabolic process (GO:0009064) | 2.57609345 |
| 141 | oxidative demethylation (GO:0070989) | 2.57026076 |
| 142 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.55919872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.19371330 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.05759742 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.43914574 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.30244742 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.15494642 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.02753496 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92322902 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13970599 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.91683405 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90452629 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04463654 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99661979 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.86070193 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.56275022 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51668435 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41260901 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30233935 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.29482931 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20448647 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20149489 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19940964 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10921202 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.05742263 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.03066540 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02796914 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5942345 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90757149 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80768350 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.78887025 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.76266705 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73870929 |
| 32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.72581490 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.72240190 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71163210 |
| 35 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.70931075 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68642257 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68262675 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62797966 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60364577 |
| 40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56691566 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55872457 |
| 42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54458690 |
| 43 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.52332201 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43839711 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43457232 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42628491 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38851973 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37518672 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36300440 |
| 50 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35499310 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34825921 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34595535 |
| 53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32412104 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30087148 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28294308 |
| 56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28036662 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26977967 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26946149 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25078097 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.24315753 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24118800 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22132362 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20968186 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15187815 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14021346 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13592825 |
| 67 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13549273 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13447058 |
| 69 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12827854 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12670160 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11598260 |
| 72 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10138108 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09954536 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09230368 |
| 75 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08363444 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07991562 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07498048 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.05989540 |
| 79 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05822178 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05552732 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05238611 |
| 82 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05154459 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02889172 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99114040 |
| 85 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98333407 |
| 86 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98216390 |
| 87 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97579682 |
| 88 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.97426618 |
| 89 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97375423 |
| 90 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95868342 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95467067 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94031605 |
| 93 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93980287 |
| 94 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.93923288 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93452309 |
| 96 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92989215 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92685754 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92096529 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91132979 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90227811 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89287008 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87433267 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83953169 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81399475 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79044320 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77147044 |
| 107 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.76575415 |
| 108 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72368779 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72090852 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71673149 |
| 111 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69802564 |
| 112 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.68711847 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68619092 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.66827583 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65777592 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65130794 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64383529 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64006712 |
| 119 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63475030 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.62451017 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.62113973 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61791778 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61017081 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60232951 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59736324 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59663283 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58834111 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58834111 |
| 129 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.57737379 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57371341 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57262788 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57231566 |
| 133 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56600538 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56553200 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56540761 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56419377 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56359636 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56038659 |
| 139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54892785 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52875469 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52781080 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52542195 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51485333 |
| 144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51223883 |
| 145 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50831881 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49556642 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48657465 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47155638 |
| 149 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46611626 |
| 150 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46415969 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46352601 |
| 152 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46072651 |
| 153 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.44547345 |
| 154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43943249 |
| 155 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.43919517 |
| 156 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43812522 |
| 157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43196584 |
| 158 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42477595 |
| 159 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.42466113 |
| 160 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41831021 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41817269 |
| 162 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41741057 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41241742 |
| 164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40843535 |
| 165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.40576893 |
| 166 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.40097692 |
| 167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39981539 |
| 168 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39751002 |
| 169 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.39377703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.09122674 |
| 2 | MP0005360_urolithiasis | 7.68859332 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.98380089 |
| 4 | MP0005365_abnormal_bile_salt | 5.85492914 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94310875 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.01207853 |
| 7 | MP0003252_abnormal_bile_duct | 3.80676927 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.38410600 |
| 9 | MP0003195_calcinosis | 3.34511428 |
| 10 | MP0005332_abnormal_amino_acid | 3.14021415 |
| 11 | MP0009840_abnormal_foam_cell | 3.09152084 |
| 12 | MP0003693_abnormal_embryo_hatching | 2.79293212 |
| 13 | MP0005083_abnormal_biliary_tract | 2.73825401 |
| 14 | MP0000566_synostosis | 2.70021183 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.59990445 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.51750199 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.30130605 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.27239793 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.16389031 |
| 20 | * MP0002118_abnormal_lipid_homeostasis | 2.07591244 |
| 21 | MP0000609_abnormal_liver_physiology | 2.07356776 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 1.90590363 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.86793842 |
| 24 | MP0003868_abnormal_feces_composition | 1.86314745 |
| 25 | MP0003123_paternal_imprinting | 1.84307449 |
| 26 | MP0003111_abnormal_nucleus_morphology | 1.81764924 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.75438716 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.70086214 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.69887618 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66397600 |
| 31 | * MP0001764_abnormal_homeostasis | 1.56114935 |
| 32 | MP0003283_abnormal_digestive_organ | 1.51757865 |
| 33 | MP0005451_abnormal_body_composition | 1.45916431 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.41074822 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.37503946 |
| 36 | MP0004043_abnormal_pH_regulation | 1.36221030 |
| 37 | MP0003718_maternal_effect | 1.32870110 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.30467131 |
| 39 | MP0003878_abnormal_ear_physiology | 1.30467131 |
| 40 | MP0003186_abnormal_redox_activity | 1.30291570 |
| 41 | MP0009697_abnormal_copulation | 1.29334450 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.24281512 |
| 43 | MP0008932_abnormal_embryonic_tissue | 1.20714520 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.20158549 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.17060817 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.15561545 |
| 47 | MP0001730_embryonic_growth_arrest | 1.12798961 |
| 48 | * MP0000598_abnormal_liver_morphology | 1.12561278 |
| 49 | MP0002938_white_spotting | 1.09831468 |
| 50 | MP0002249_abnormal_larynx_morphology | 1.08597102 |
| 51 | MP0003011_delayed_dark_adaptation | 1.06828977 |
| 52 | MP0003077_abnormal_cell_cycle | 1.05144879 |
| 53 | MP0003315_abnormal_perineum_morphology | 1.03817532 |
| 54 | * MP0002078_abnormal_glucose_homeostasis | 1.02783511 |
| 55 | MP0001756_abnormal_urination | 1.02050641 |
| 56 | MP0000537_abnormal_urethra_morphology | 1.01942312 |
| 57 | MP0000604_amyloidosis | 1.00396106 |
| 58 | MP0005670_abnormal_white_adipose | 0.99497166 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 0.96514440 |
| 60 | * MP0009642_abnormal_blood_homeostasis | 0.95167185 |
| 61 | MP0003879_abnormal_hair_cell | 0.94957441 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.93039494 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 0.92412709 |
| 64 | MP0009764_decreased_sensitivity_to | 0.91850163 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.90396487 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 0.89727706 |
| 67 | MP0005647_abnormal_sex_gland | 0.89664618 |
| 68 | MP0002697_abnormal_eye_size | 0.89548763 |
| 69 | MP0009763_increased_sensitivity_to | 0.89211849 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 0.88232153 |
| 71 | MP0008469_abnormal_protein_level | 0.88203040 |
| 72 | MP0005535_abnormal_body_temperature | 0.86941165 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 0.86287058 |
| 74 | MP0000462_abnormal_digestive_system | 0.85351253 |
| 75 | MP0001293_anophthalmia | 0.84962172 |
| 76 | MP0005408_hypopigmentation | 0.84242125 |
| 77 | MP0004130_abnormal_muscle_cell | 0.84194084 |
| 78 | MP0002971_abnormal_brown_adipose | 0.81548276 |
| 79 | MP0003122_maternal_imprinting | 0.80507054 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.80391424 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.79018760 |
| 82 | MP0004858_abnormal_nervous_system | 0.78227926 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.77896099 |
| 84 | MP0002163_abnormal_gland_morphology | 0.77668886 |
| 85 | MP0000490_abnormal_crypts_of | 0.77199810 |
| 86 | MP0008058_abnormal_DNA_repair | 0.76836842 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.76780151 |
| 88 | MP0001661_extended_life_span | 0.75361634 |
| 89 | MP0005334_abnormal_fat_pad | 0.74845645 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.73780190 |
| 91 | * MP0005376_homeostasis/metabolism_phenot | 0.72332730 |
| 92 | MP0003938_abnormal_ear_development | 0.70750271 |
| 93 | MP0004233_abnormal_muscle_weight | 0.70683838 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.70305547 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.69685400 |
| 96 | MP0001529_abnormal_vocalization | 0.69586721 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.69485912 |
| 98 | MP0005330_cardiomyopathy | 0.68955497 |
| 99 | MP0003329_amyloid_beta_deposits | 0.67213281 |
| 100 | MP0005380_embryogenesis_phenotype | 0.66360748 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 0.66360748 |
| 102 | MP0005266_abnormal_metabolism | 0.65714193 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.65423898 |
| 104 | MP0001697_abnormal_embryo_size | 0.64918246 |
| 105 | MP0002254_reproductive_system_inflammat | 0.63743827 |
| 106 | MP0002928_abnormal_bile_duct | 0.63064747 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.61706571 |
| 108 | MP0003119_abnormal_digestive_system | 0.60567035 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.60125106 |
| 110 | MP0005501_abnormal_skin_physiology | 0.59794142 |
| 111 | MP0004133_heterotaxia | 0.59633005 |
| 112 | MP0003984_embryonic_growth_retardation | 0.59371126 |
| 113 | MP0005448_abnormal_energy_balance | 0.58825488 |
| 114 | MP0002080_prenatal_lethality | 0.58590885 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.57957671 |
| 116 | MP0002085_abnormal_embryonic_tissue | 0.57796662 |
| 117 | MP0002796_impaired_skin_barrier | 0.57631125 |
| 118 | MP0003953_abnormal_hormone_level | 0.57469678 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.56958100 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.56366170 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.55543282 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.54491250 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.50465550 |
| 124 | MP0003690_abnormal_glial_cell | 0.49242204 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.45381776 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.44519879 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.43986914 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.43822932 |
| 129 | MP0005395_other_phenotype | 0.43177847 |
| 130 | MP0009672_abnormal_birth_weight | 0.42955898 |
| 131 | MP0002168_other_aberrant_phenotype | 0.41247782 |
| 132 | MP0002822_catalepsy | 0.41157776 |
| 133 | MP0008874_decreased_physiological_sensi | 0.38528370 |
| 134 | MP0009053_abnormal_anal_canal | 0.38410081 |
| 135 | MP0002269_muscular_atrophy | 0.38091632 |
| 136 | MP0008873_increased_physiological_sensi | 0.37378925 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.37185875 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.36894727 |
| 139 | MP0003959_abnormal_lean_body | 0.36794316 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.35784580 |
| 141 | MP0002970_abnormal_white_adipose | 0.35166470 |
| 142 | MP0003075_altered_response_to | 0.34993427 |
| 143 | MP0005166_decreased_susceptibility_to | 0.33991569 |
| 144 | MP0003724_increased_susceptibility_to | 0.32650260 |
| 145 | MP0003436_decreased_susceptibility_to | 0.30973445 |
| 146 | * MP0002135_abnormal_kidney_morphology | 0.30865410 |
| 147 | MP0009115_abnormal_fat_cell | 0.30236420 |
| 148 | MP0008872_abnormal_physiological_respon | 0.29149290 |
| 149 | * MP0001845_abnormal_inflammatory_respons | 0.28952968 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.28703345 |
| 151 | MP0004147_increased_porphyrin_level | 0.28617446 |
| 152 | MP0000249_abnormal_blood_vessel | 0.26127353 |
| 153 | MP0005375_adipose_tissue_phenotype | 0.26111422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19716523 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.50822617 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.35850058 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.08690544 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.65540976 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.63319570 |
| 7 | * Xanthomatosis (HP:0000991) | 5.53178397 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.91304182 |
| 9 | Complement deficiency (HP:0004431) | 4.57577010 |
| 10 | Hyperammonemia (HP:0001987) | 4.57210591 |
| 11 | * Ketosis (HP:0001946) | 4.56720381 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.51501906 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.45927189 |
| 14 | Hyperglycinemia (HP:0002154) | 4.31672842 |
| 15 | Hyperglycinuria (HP:0003108) | 4.31622906 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.27361638 |
| 17 | Joint hemorrhage (HP:0005261) | 4.25465589 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.13493698 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.13493698 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10230161 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06933727 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06808535 |
| 23 | Epidermoid cyst (HP:0200040) | 3.93751809 |
| 24 | Ketoacidosis (HP:0001993) | 3.92088620 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88716213 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.81141650 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.76017748 |
| 28 | Fat malabsorption (HP:0002630) | 3.73895253 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66167367 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59419695 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47570452 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45155203 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44346510 |
| 34 | Abnormality of complement system (HP:0005339) | 3.25901052 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.23869205 |
| 36 | * Abnormality of nucleobase metabolism (HP:0010932) | 3.22584028 |
| 37 | * Abnormality of purine metabolism (HP:0004352) | 3.10761031 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.09849735 |
| 39 | Hypoglycemic seizures (HP:0002173) | 3.08369257 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.05667376 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.05656529 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.98917433 |
| 43 | Reticulocytopenia (HP:0001896) | 2.98384080 |
| 44 | * Metabolic acidosis (HP:0001942) | 2.92489834 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89314438 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.89314438 |
| 47 | Late onset (HP:0003584) | 2.81044281 |
| 48 | Lethargy (HP:0001254) | 2.79533454 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.76265994 |
| 50 | Megaloblastic anemia (HP:0001889) | 2.73880423 |
| 51 | * Gout (HP:0001997) | 2.72482327 |
| 52 | Steatorrhea (HP:0002570) | 2.71669450 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.61069125 |
| 54 | Hyperphosphaturia (HP:0003109) | 2.60858153 |
| 55 | Cerebral edema (HP:0002181) | 2.60223997 |
| 56 | Irritability (HP:0000737) | 2.58868503 |
| 57 | Vascular calcification (HP:0004934) | 2.56423482 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.56201479 |
| 59 | Alkalosis (HP:0001948) | 2.56061018 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.54791672 |
| 61 | Skin nodule (HP:0200036) | 2.54306879 |
| 62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.50247613 |
| 63 | Myopathic facies (HP:0002058) | 2.49380502 |
| 64 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.48617968 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.48454566 |
| 66 | Macrocytic anemia (HP:0001972) | 2.46398568 |
| 67 | Spontaneous abortion (HP:0005268) | 2.45937603 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.44367903 |
| 69 | Neonatal onset (HP:0003623) | 2.44062475 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.41050398 |
| 71 | * Hepatocellular carcinoma (HP:0001402) | 2.40671154 |
| 72 | Malnutrition (HP:0004395) | 2.37972619 |
| 73 | Vomiting (HP:0002013) | 2.37595985 |
| 74 | Myocardial infarction (HP:0001658) | 2.36938654 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.36161486 |
| 76 | Glycosuria (HP:0003076) | 2.36161486 |
| 77 | Abnormal urine phosphate concentration (HP:0012599) | 2.35571284 |
| 78 | Spastic diplegia (HP:0001264) | 2.35155644 |
| 79 | Symptomatic seizures (HP:0011145) | 2.33079875 |
| 80 | Cholelithiasis (HP:0001081) | 2.32105481 |
| 81 | Cholecystitis (HP:0001082) | 2.31814704 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.31814704 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.30565252 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.30552161 |
| 85 | Rhabdomyolysis (HP:0003201) | 2.28526905 |
| 86 | Acute encephalopathy (HP:0006846) | 2.25240695 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.23927171 |
| 88 | Vaginal fistula (HP:0004320) | 2.22856060 |
| 89 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.22385401 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.22212891 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.20526482 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.20526482 |
| 93 | Abnormality of vitamin B metabolism (HP:0004340) | 2.19975248 |
| 94 | Acanthocytosis (HP:0001927) | 2.17376291 |
| 95 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.16965420 |
| 96 | Mitral stenosis (HP:0001718) | 2.14690844 |
| 97 | Rickets (HP:0002748) | 2.11526944 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11039599 |
| 99 | Abnormality of reticulocytes (HP:0004312) | 2.10624712 |
| 100 | Brushfield spots (HP:0001088) | 2.09721848 |
| 101 | Hyperglycemia (HP:0003074) | 2.09720953 |
| 102 | Glomerulonephritis (HP:0000099) | 2.07594288 |
| 103 | Chromsome breakage (HP:0040012) | 2.06156310 |
| 104 | * Increased purine levels (HP:0004368) | 2.04367008 |
| 105 | * Hyperuricemia (HP:0002149) | 2.04367008 |
| 106 | * Pancreatitis (HP:0001733) | 2.01870367 |
| 107 | Osteomalacia (HP:0002749) | 2.01278542 |
| 108 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.01210126 |
| 109 | Opisthotonus (HP:0002179) | 1.99027569 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 1.98838103 |
| 111 | Hepatic necrosis (HP:0002605) | 1.97935150 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94685057 |
| 113 | Myoglobinuria (HP:0002913) | 1.93704688 |
| 114 | Ileus (HP:0002595) | 1.93404487 |
| 115 | Bifid scrotum (HP:0000048) | 1.93269384 |
| 116 | Exercise-induced myalgia (HP:0003738) | 1.92594204 |
| 117 | Menorrhagia (HP:0000132) | 1.92126928 |
| 118 | Amyloidosis (HP:0011034) | 1.91622271 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89877490 |
| 120 | Elevated alkaline phosphatase (HP:0003155) | 1.88753064 |
| 121 | Esophageal varix (HP:0002040) | 1.88195176 |
| 122 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87815992 |
| 123 | Nausea (HP:0002018) | 1.85977058 |
| 124 | Renal cortical cysts (HP:0000803) | 1.85364409 |
| 125 | Thrombophlebitis (HP:0004418) | 1.84755255 |
| 126 | Acute hepatic failure (HP:0006554) | 1.84036656 |
| 127 | Cerebral palsy (HP:0100021) | 1.80902008 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.79781742 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.79761567 |
| 130 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79577256 |
| 131 | Acute necrotizing encephalopathy (HP:0006965) | 1.78984273 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.78338449 |
| 133 | Exercise-induced muscle cramps (HP:0003710) | 1.77949857 |
| 134 | Microvesicular hepatic steatosis (HP:0001414) | 1.72344378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17805486 |
| 2 | ERN1 | 4.23948109 |
| 3 | FGFR4 | 4.10030772 |
| 4 | INSRR | 4.06627219 |
| 5 | SIK1 | 3.71992120 |
| 6 | BUB1 | 3.52939377 |
| 7 | VRK2 | 2.94187009 |
| 8 | TAOK3 | 2.80131063 |
| 9 | NME2 | 2.77205888 |
| 10 | EPHA2 | 2.69761311 |
| 11 | TTK | 2.51352571 |
| 12 | ACVR1B | 2.48288040 |
| 13 | TRIB3 | 2.46001455 |
| 14 | NME1 | 2.43211200 |
| 15 | CDC7 | 2.41476584 |
| 16 | PKN2 | 2.25257264 |
| 17 | WNK4 | 2.25170603 |
| 18 | ERBB4 | 2.17624082 |
| 19 | FLT3 | 2.14448016 |
| 20 | SMG1 | 2.13650529 |
| 21 | PBK | 2.04573279 |
| 22 | WNK3 | 2.00395449 |
| 23 | MAP2K4 | 1.93761445 |
| 24 | MST1R | 1.90827265 |
| 25 | PIK3CG | 1.82508097 |
| 26 | EIF2AK1 | 1.82029423 |
| 27 | ICK | 1.78015850 |
| 28 | MAPK11 | 1.77964739 |
| 29 | STK16 | 1.71825065 |
| 30 | EEF2K | 1.67956591 |
| 31 | SRPK1 | 1.62357129 |
| 32 | TESK2 | 1.61839568 |
| 33 | MAPK15 | 1.59915890 |
| 34 | PTK6 | 1.44405330 |
| 35 | BRSK1 | 1.44227702 |
| 36 | WEE1 | 1.37938587 |
| 37 | OXSR1 | 1.35733363 |
| 38 | PINK1 | 1.34796858 |
| 39 | FRK | 1.34257828 |
| 40 | PLK1 | 1.28880149 |
| 41 | TYK2 | 1.23714171 |
| 42 | MAP2K3 | 1.21717850 |
| 43 | ARAF | 1.21291998 |
| 44 | NEK9 | 1.20990972 |
| 45 | BRAF | 1.18932108 |
| 46 | MAP3K7 | 1.18853613 |
| 47 | JAK2 | 1.18236833 |
| 48 | BRSK2 | 1.16513783 |
| 49 | AURKB | 1.12433691 |
| 50 | DAPK2 | 1.12067358 |
| 51 | CDK7 | 1.09817378 |
| 52 | VRK1 | 1.09166612 |
| 53 | PRKAA2 | 1.08686779 |
| 54 | GRK6 | 1.08653371 |
| 55 | ABL2 | 1.08367188 |
| 56 | EPHA3 | 1.06283719 |
| 57 | KDR | 1.05535847 |
| 58 | EPHB1 | 1.04326185 |
| 59 | SCYL2 | 0.96978215 |
| 60 | MAP3K8 | 0.96769999 |
| 61 | PAK4 | 0.96616173 |
| 62 | MAP3K3 | 0.95976923 |
| 63 | NEK2 | 0.95927529 |
| 64 | PDK3 | 0.95379777 |
| 65 | PDK4 | 0.95379777 |
| 66 | STK38L | 0.93552077 |
| 67 | PLK3 | 0.92190306 |
| 68 | AKT2 | 0.91440860 |
| 69 | MAP3K10 | 0.90198395 |
| 70 | CHEK2 | 0.87738069 |
| 71 | STK4 | 0.87252746 |
| 72 | LATS1 | 0.87180030 |
| 73 | AURKA | 0.86605070 |
| 74 | DYRK1B | 0.86204250 |
| 75 | RIPK1 | 0.85668771 |
| 76 | IRAK3 | 0.85494359 |
| 77 | JAK1 | 0.84620471 |
| 78 | PRKG2 | 0.84618707 |
| 79 | MET | 0.82354384 |
| 80 | PTK2 | 0.82215273 |
| 81 | ATR | 0.81993003 |
| 82 | OBSCN | 0.80668290 |
| 83 | TBK1 | 0.80368502 |
| 84 | CDK4 | 0.80015045 |
| 85 | CDK8 | 0.79476842 |
| 86 | CHEK1 | 0.79115137 |
| 87 | PRKAA1 | 0.78871585 |
| 88 | MAP2K6 | 0.77067489 |
| 89 | TAOK1 | 0.75949641 |
| 90 | MAP3K2 | 0.75892786 |
| 91 | PRKCI | 0.74756548 |
| 92 | MAPK4 | 0.74559765 |
| 93 | PLK4 | 0.74126507 |
| 94 | RPS6KB2 | 0.74077765 |
| 95 | PRKCZ | 0.73691554 |
| 96 | PRKACG | 0.73277433 |
| 97 | SGK3 | 0.71383926 |
| 98 | GSK3A | 0.71210271 |
| 99 | TESK1 | 0.70107541 |
| 100 | TIE1 | 0.70001361 |
| 101 | SGK494 | 0.69911082 |
| 102 | SGK223 | 0.69911082 |
| 103 | LMTK2 | 0.67857399 |
| 104 | CSNK2A1 | 0.67676038 |
| 105 | BMX | 0.67296059 |
| 106 | NEK1 | 0.66908050 |
| 107 | MAPK12 | 0.66884512 |
| 108 | CSNK2A2 | 0.66654601 |
| 109 | ERBB2 | 0.64463038 |
| 110 | PDPK1 | 0.64408020 |
| 111 | ZAK | 0.64025001 |
| 112 | IRAK1 | 0.62622707 |
| 113 | MAP3K11 | 0.61980108 |
| 114 | PIM2 | 0.61352491 |
| 115 | FGFR2 | 0.60915537 |
| 116 | SGK2 | 0.57887385 |
| 117 | CAMK2G | 0.56175319 |
| 118 | CSK | 0.55699763 |
| 119 | CDK2 | 0.51860562 |
| 120 | CDK1 | 0.51544088 |
| 121 | RET | 0.50472971 |
| 122 | TGFBR2 | 0.49494073 |
| 123 | KSR2 | 0.48936276 |
| 124 | MAP3K14 | 0.48661999 |
| 125 | MAP3K1 | 0.48058646 |
| 126 | MST4 | 0.48030326 |
| 127 | ATM | 0.46633610 |
| 128 | LRRK2 | 0.46381281 |
| 129 | PDK1 | 0.44688559 |
| 130 | FGFR1 | 0.44477104 |
| 131 | CAMK2D | 0.44393253 |
| 132 | CCNB1 | 0.41465369 |
| 133 | PRKCQ | 0.40628387 |
| 134 | MAP2K1 | 0.40530251 |
| 135 | EPHA4 | 0.38825151 |
| 136 | CSNK1A1 | 0.38779298 |
| 137 | CSNK1E | 0.38775934 |
| 138 | FGFR3 | 0.37158566 |
| 139 | MAP3K5 | 0.37147582 |
| 140 | TLK1 | 0.36956575 |
| 141 | PAK1 | 0.36800385 |
| 142 | HIPK2 | 0.35843262 |
| 143 | MAP2K2 | 0.34543181 |
| 144 | IGF1R | 0.34182144 |
| 145 | PAK3 | 0.33659491 |
| 146 | IRAK2 | 0.32841040 |
| 147 | CAMK1D | 0.32708926 |
| 148 | PRKCG | 0.32604255 |
| 149 | DYRK2 | 0.31259776 |
| 150 | PDK2 | 0.30673968 |
| 151 | MAPK7 | 0.29741852 |
| 152 | CSNK1G1 | 0.27693410 |
| 153 | PRKCA | 0.26579589 |
| 154 | ITK | 0.26168417 |
| 155 | MTOR | 0.26015775 |
| 156 | CDK6 | 0.25746108 |
| 157 | PRKCH | 0.25416606 |
| 158 | CSF1R | 0.23526326 |
| 159 | ZAP70 | 0.23320014 |
| 160 | PASK | 0.23008800 |
| 161 | IKBKE | 0.22696607 |
| 162 | MAP3K6 | 0.22550552 |
| 163 | PHKG2 | 0.21945330 |
| 164 | PHKG1 | 0.21945330 |
| 165 | STK39 | 0.21101234 |
| 166 | PRKACA | 0.20642969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12209357 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33413273 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32581742 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32034277 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90665631 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75664517 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73899455 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58779820 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57401155 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52808532 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49080979 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39382884 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38636739 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29173435 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.16225745 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11294794 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95604338 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84974825 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81245022 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80868219 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79626848 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78953729 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72370254 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71708880 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71327051 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68522298 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68271949 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.66692072 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66334351 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66244537 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65949295 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64449246 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57397118 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55198323 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54593535 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52765250 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.50109757 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47734939 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43948736 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43467588 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40825596 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 1.35330054 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32233717 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32011252 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.31319733 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29441175 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28493788 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27003851 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25754793 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20064744 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.16779343 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14088159 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11491344 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06530402 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05272229 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04838393 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02427001 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99690305 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93180525 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92168784 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.88696493 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87786368 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.86734750 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78146501 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 0.72452604 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71479181 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71166381 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70863724 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69017140 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68487956 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64113110 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62583439 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61676952 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55949183 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51115888 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49229459 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48856390 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47661453 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47273696 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.46009999 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44998588 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41165470 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.36235358 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.35048719 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33826984 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31689721 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.30818670 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30791614 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.27947623 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.27820316 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.26345545 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.26312396 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25924340 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22707339 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22651081 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17522497 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15931062 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12466168 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10847774 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08778555 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04285826 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03158391 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01088484 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00157660 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1552464 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | -0.1525349 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1477682 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1392474 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1355824 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1306841 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1298094 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1237822 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0920426 |
| 114 | Lysosome_Homo sapiens_hsa04142 | -0.0820765 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0695364 |
| 116 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0692909 |
| 117 | Protein export_Homo sapiens_hsa03060 | -0.0680035 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0487218 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0253352 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0213968 |

